Boryung Pharm & Lilly sign marketing and partnership agreements of Prozac and Strattera

Published: 2017-03-20 15:47:27

Updated: 2017-03-20 15:47:27

On the 15^th, Boryung Pharm(CEO Tae-Hong Choi) and Lilly Korea(CEO Paul Henry Huibers) signed a marketing and partnership agreement of the antidepressant Prozac(generic name: fluoxetine) and the attention-deficit/hyperactivity disorder(ADHD) treatment Strattera(generic name: atomoxetine).

Prozac, the first globally-prescribed selective serotonin reuptake inhibitors(SSRI) antidepressant, was app...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.